Table 3

Partial Spearman correlation coefficients of IGF-I, IGFBP-2, and IGFBP-3 concentrations and molar ratio of IGF-I to IGFBP-3 at gestational weeks 10–14 with subsequent fasting plasma biomarkers at gestational weeks 15–26 among case subjects with GDM and control subjects without GDM*

Case subjects
 Molar ratio of IGF-I to IGFBP-30.360.130.37−0.21
Control subjects
 Molar ratio of IGF-I to IGFBP-30.15−0.050.17−0.13
  • *P values were adjusted for age, gestational age at blood collection, family history of diabetes, and prepregnancy BMI.

  • P < 0.05.

  • P < 0.001.

  • §P < 0.01.